LEADER 01320nam  2200349Ia 450 
001 9910698827303321
005 20090528120852.0
035   $a(CKB)5470000002397595
035   $a(OCoLC)355288915
035   $a(EXLCZ)995470000002397595
100   $a20090528d2001      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $einformation request and discipline review letters under the prescription drug user fee act
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research :$cCenter for Drug Evaluation and Research,$d[2001]
215   $a5 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 28, 2009).
300   $a"November 2001".
517   $aGuidance for industry 
606   $aDrugs$xGovernment policy$zUnited States
615  0$aDrugs$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698827303321
996   $aGuidance for industry$93434577
997   $aUNINA